Back
Chocoladefabriken Lindt & Spruengli AG Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
72
CHLSY
Chocoladefabriken Lindt & Spruengli AG
Last Price:
$15.09
Seasonality Move:
10.46%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
$53.80
Seasonality Move:
12.51%
Buy
72
Chocoladefabriken Lindt & Spruengli AG (CHLSY)
is a Buy
Is Chocoladefabriken Lindt & Spruengli AG a Buy, Sell or Hold?
-
The current Chocoladefabriken Lindt & Spruengli AG [CHLSY] share price is $14.50. The Score for CHLSY is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
CHLSY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $53.94. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CHLSY Stock Price Chart
What is Chocoladefabriken Lindt & Spruengli AG's stock price today?
-
The Chocoladefabriken Lindt & Spruengli AG share price today is $14.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CHLSY is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $53.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
CHLSY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 65.85 | Buy |
Chaikin Money Flow: | -18719 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.28 - 14.16) | Buy |
Bollinger Bands (100): | (10.96 - 13.3) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -10.59 | Sell |
Relative Strength Index (14 RSI): | 31.57 | Sell |
Chaikin Money Flow: | -108555 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.57 - 82.31) | Sell |
Bollinger Bands (100): | (80.58 - 128.2) | Sell |
CHLSY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.2 | Buy |
20-day SMA: | 13.8 | Buy |
50-day SMA: | 13.05 | Buy |
200-day SMA: | 12.32 | Buy |
8-day EMA: | 14.28 | Buy |
20-day EMA: | 13.89 | Buy |
50-day EMA: | 13.22 | Buy |
200-day EMA: | 12.71 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.71 | Buy |
20-day SMA: | 61.78 | Sell |
50-day SMA: | 87.56 | Sell |
200-day SMA: | 119.05 | Sell |
8-day EMA: | 54.67 | Sell |
20-day EMA: | 63.17 | Sell |
50-day EMA: | 81.41 | Sell |
200-day EMA: | 108.77 | Sell |
Chocoladefabriken Lindt & Spruengli AG Earnings Growth & CHLSY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.
Chocoladefabriken Lindt & Spruengli AG Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |